DEFA14A ·Filed Apr 1, 2026

ZBH

ZIMMER BIOMET HOLDINGS, INC.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-135667
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual proxy filing. Traders should note the board's stance against the shareholder proposal, which could indicate governance concerns, but no immediate market-moving events are expected. Monitor for any related activist activity or governance discussions.

DirectionNeutral
Confidencelow
Horizonimmediate
Final — all horizons settled through T+60d
ZBH ▲ +2.31% at T+60d
NEUTRAL call ✓ call won +2.31% · α vs SPY -8.94% · entry $91.00 → $93.10
Entry anchored
Mar 31, 03:59 PM ET
via exchange tick
T+1d
-0.22%
call -0.22% · α -0.30%
$90.80
settled 6mo ago
T+5d
+2.24%
call +2.24% · α -1.53%
$93.03
settled 6mo ago
T+20d
-12.01%
call -12.01% · α -21.73%
$80.07
settled 5mo ago
T+60d
+2.31%
call +2.31% · α -8.94%
$93.10
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Zimmer Biomet Holdings, Inc. (ZBH) filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting. The filing outlines several voting items, including the election of ten directors, ratification of auditors, a non-binding Say on Pay vote, and a shareholder proposal on an independent board chairman. The board recommends voting FOR all nominees and FOR ratification of auditors, but AGAINST the shareholder proposal. Analysis based on filing metadata only — document content was unavailable.

Key Facts

  • Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
  • Voting items include election of 10 directors, auditor ratification, Say on Pay, and a shareholder proposal for an independent board chairman.
  • Board recommends FOR all director nominees and auditor ratification, but AGAINST the shareholder proposal.
  • Meeting date is May 22, 2026.

Financial Impact

No direct financial impact from this filing; it is a routine disclosure for shareholder voting.

Risk Factors

  • Potential for shareholder dissent on the independent board chairman proposal, though impact is likely low.
  • Routine filing, so no significant financial or operational risks are indicated.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-135667
Document: 0001193125-26-135667-index-headers.html0001193125-26-135667
Document: 0001193125-26-135667-index.html0001193125-26-135667
Document: 0001193125-26-135667.txt0001193125-26-135667
9 reports for ZBH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZBH — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$98.41 $93.98▼ −4.50%▼ −6.63%$88.25 (−10.32%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 2/10
$99.50 $92.44▼ −7.10%▼ −6.14%$88.25 (−11.31%)
Aug 17, 2026
6w ago
Court Ruling
NEUTRAL ★ 2/10
$98.20 $100.98▲ +2.83%▲ +4.02%$88.25 (−10.13%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$98.16 $97.89▼ −0.28%▼ −0.63%$88.25 (−10.10%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$83.34 $85.14▲ +2.16%▲ +2.09%$88.25 (+5.90%)
May 1, 2026
22w ago
Court Ruling
NEUTRAL ★ 3/10
$82.86 $83.37▲ +0.62%▼ −1.73%$88.25 (+6.51%)
Apr 28, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$82.45 $82.63▲ +0.22%▼ −1.47%$88.25 (+7.04%)
Apr 28, 2026
22w ago
8-K
BULLISH ★ 8/10
$82.45 $82.63▲ +0.22%▼ −1.47%$88.25 (+7.04%)
Apr 1, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$91.00 $93.03▲ +2.24%▼ −1.53%$88.25 (−3.02%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access